NEWS

5-6 June 2024  
sedivention at the health.tech conference in Munich, Germany

sedivention takes part, showcases and meets investors at the health.tech conference in Munich, innovation & business for better healthcare.

19 September 2023  
sedivention presents at Life Science Intelligence (LSI) Europe '23, Barcelona, Spain 

sedivention presents its innovative medical device and novel therapy during the LSI Europe '23 conference in Barcelona (Spain).

At the EMERGING MEDTECH SUMMIT 2023 taking place in Barcelona 18-22 September 2023, sedivention connected with the leading partners, innovators, investores, and strategics building medtech companies.  

Presenting innovators like sedivention are an essential component of LSI Emerging Medtech Summits, showcasing the latest breakthroughs and developments in the medical technology sector.

Video presentation (19 September 2023)

28 August 2023  
Bavarian start-up scene recognizes novel therapy for obesity from sedivention

sedivention and its novel therapy for obesity recognized in Bavarian the start-up scene.

Press release Munich Startup (28 August 2023)

Press release Gruenderland Bayern (29 August 2023)

26 July 2023  
Second place for sedivention at BayStartUP Munich Business Plan Competition 

sedivention took part in the third phase of the Munich Business Plan Competition and convinced the judges with its promising business concept.

Treatment of obesity by obliterating the "hunger nerve" from inside the stomach: sedivention is developing a cryo-catheter and a cryo-ballon, the "Blizzard Balloon", to treat obesity. The nerve fibers that transmit the feeling of hunger from the stomach to the brain are sclerosed from the stomach using cold - on an outpatient and non-invasive basis. The patient then no longer feels hungry and can lose weight more easily.

Press release BayStartUP (26 July 2023)

Press release Foerderbank Bayern (LfA) (27 July 2023)

Press release Bavarian Biotech Cluster Development (27 July 2023)

26 June 2023  
Science4Life awards sedivention for its outstanding business idea

Development of a medical device for an one-off, outpatient treatment against obesity: similar to a gastroscopy, the nerves that transmit the feeling of hunger from the stomach to the brain are sclerosed. This reduces the feeling of hunger and makes it easier to lose weight. Without implants, surgery or medication.

Press release Science4Life (26. June 2023)

24 May 2023  
sedivention wins 1st place from BayStartUP - Munich Business Plan Competition

New medical device and innovative therapy convices jury.

sedivention has been awarded with the 1st place from BayStartUP for its development of a new medical device and innovative therapy. 

The sedivention team took part in phase 2 of the Munich Business Plan Competition 2023 and impressed the judges with its promising business concept.

The therapy allows a minimally invasive, outpatient one-time treatment to freezing the "hunger nerve" and cuts down costs and miminizes complications of obesity therapy.

For sedivention as high-tech start-up in the medtech sector, the Munich Business Plan Competition offers fantastic opportunities to network with other start-ups and exchange experiences. The most important experience during the competition, is the constructive criticism the team received from the honorary judges, which helps the sedivention team to develop further the business idea and driving it to success.

Press release of BayStartUP (24.05.2023)

14 March 2023  
BayStartUP nominates sedivention to be one of the 10 most successfull start-ups 

The Munich Business Plan Competition 2023 comes to its final phase and sedivention is nominated as one of the top 10 start-ups. 

The jury was impressed by the innovative therapy and convinced that sedivention's business model and approach will be successful on the market.

Press release of BayStartUP (14.03.2023)

Home            Imprint          Privacy Policy         Disclaimer

© Sedivention GmbH 2024 - All rights reserved

Wir benötigen Ihre Zustimmung zum Laden der Übersetzungen

Wir nutzen einen Drittanbieter-Service, um den Inhalt der Website zu übersetzen, der möglicherweise Daten über Ihre Aktivitäten sammelt. Bitte überprüfen Sie die Details in der Datenschutzerklärung und akzeptieren Sie den Dienst, um die Übersetzungen zu sehen.